(LEN) Lennar - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5260571048
LEN: Houses, Land, Mortgages, Insurance, Loans, Rentals
Lennar Corporation, a prominent player in the homebuilding industry, operates through multiple segments including Homebuilding East, Central, Texas, West, Financial Services, Multifamily, and Lennar Other. This diversification allows the company to spread risk and capitalize on various market opportunities across the U.S. Their homebuilding operations encompass the construction and sale of single-family attached and detached homes, as well as land development for residential use.
Beyond homebuilding, Lennars financial services division offers mortgage financing, title insurance, and closing services, creating an additional revenue stream and enhancing customer convenience. The multifamily segment focuses on developing and managing rental properties, further diversifying their portfolio and income sources.
With a strong market position, Lennar targets a broad demographic, including first-time buyers, move-up purchasers, active adults, and luxury seekers. Their extensive geographic reach across the U.S. helps mitigate regional market risks, a strategic advantage in the cyclical homebuilding industry.
Financially, Lennar boasts a market cap of over $32 billion, with a P/E ratio of 8.65 and a forward P/E of 9.74, indicating reasonable valuation. The price-to-book ratio of 1.18 suggests modest equity valuation relative to book value. Investors should consider these metrics alongside industry cyclicality and Lennars demonstrated ability to manage risks through diversified operations and strategic land management.
For investors and fund managers, Lennars diversified approach and additional revenue streams present a stable investment opportunity in a competitive industry. Their strategic focus on managing land holdings and adapting to market demands underscores their resilience and potential for sustained growth.
Additional Sources for LEN Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
LEN Stock Overview
Market Cap in USD | 30,579m |
Sector | Consumer Cyclical |
Industry | Residential Construction |
GiC Sub-Industry | Homebuilding |
IPO / Inception | 1987-11-05 |
LEN Stock Ratings
Growth 5y | 64.7% |
Fundamental | 36.1% |
Dividend | 64.7% |
Rel. Strength Industry | -15.6 |
Analysts | 3.57/5 |
Fair Price Momentum | 124.88 USD |
Fair Price DCF | 186.21 USD |
LEN Dividends
Dividend Yield 12m | 1.43% |
Yield on Cost 5y | 7.41% |
Annual Growth 5y | 26.11% |
Payout Consistency | 83.7% |
LEN Growth Ratios
Growth Correlation 3m | -83.3% |
Growth Correlation 12m | -32.3% |
Growth Correlation 5y | 85.4% |
CAGR 5y | 35.29% |
CAGR/Max DD 5y | 0.80 |
Sharpe Ratio 12m | -0.73 |
Alpha | -31.20 |
Beta | 0.86 |
Volatility | 34.65% |
Current Volume | 3082.9k |
Average Volume 20d | 2763k |
As of March 21, 2025, the stock is trading at USD 120.30 with a total of 3,082,900 shares traded.
Over the past week, the price has changed by +1.15%, over one month by -0.53%, over three months by -9.88% and over the past year by -21.11%.
Partly, yes. Based on ValueRay Fundamental Analyses, Lennar (NYSE:LEN) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.14 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LEN as of March 2025 is 124.88. This means that LEN is currently overvalued and has a potential downside of 3.81%.
Lennar has received a consensus analysts rating of 3.57. Therefor, it is recommend to hold LEN.
- Strong Buy: 5
- Buy: 3
- Hold: 12
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, LEN Lennar will be worth about 139.4 in March 2026. The stock is currently trading at 120.30. This means that the stock has a potential upside of +15.86%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 152.2 | 26.5% |
Analysts Target Price | 162.2 | 34.8% |
ValueRay Target Price | 139.4 | 15.9% |